1-2 of 2
Bing Carter, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Development of Triptolide Derivative MRx102 as a Therapeutic Agent for Acute Myeloid Leukemia

John M. Fidler, Ph.D., Jinhua An, Ph.D., John H. Musser, Ph.D., Duncan H. Mak, M.S., Bing Carter, Ph.D., Michael Andreeff, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3271.
https://doi.org/10.1182/blood.V116.21.3271.3271
Published: 2010
Journal Articles

Targeting XIAP and ARC (apoptosis repressor with caspase recruitment domain) Overcomes Imatinib Resitance In Blast Crisis CML Cells.

Bing Carter, Ph.D., Duncan H. Mak, M.S., Wendy D. Schober, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Erich Koller, Ziwei Huang, John C. Reed, MD, PhD, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2010) 116 (21): 3415.
https://doi.org/10.1182/blood.V116.21.3415.3415
Published: 2010